Found: 10
Select item for more details and to access through your institution.
Complement regulator factor H in multiple sclerosis.
- Published in:
- Journal of Cellular Biochemistry, 2011, v. 112, n. 10, p. 2653, doi. 10.1002/jcb.23204
- By:
- Publication type:
- Article
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 8, p. 979, doi. 10.1177/13524585231185247
- By:
- Publication type:
- Article
Cerebrospinal fluid complement system biomarkers in demyelinating disease.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 14, p. 1929, doi. 10.1177/1352458519887905
- By:
- Publication type:
- Article
Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 7, p. 946, doi. 10.1177/1352458516669002
- By:
- Publication type:
- Article
COVID‐19 Vaccine Response in People with Multiple Sclerosis.
- Published in:
- Annals of Neurology, 2022, v. 91, n. 1, p. 89, doi. 10.1002/ana.26251
- By:
- Publication type:
- Article
Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis.
- Published in:
- Journal of Extracellular Vesicles, 2017, v. 6, n. 1, p. N.PAG, doi. 10.1080/20013078.2017.1369805
- By:
- Publication type:
- Article
A blood-based metabolomics test to distinguish relapsing–remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-69119-3
- By:
- Publication type:
- Article
Seroprevalence of Molluscum contagiosum Virus in German and UK Populations.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0088734
- By:
- Publication type:
- Article
CSF-resident CD4<sup>+</sup> T-cells display a distinct gene expression profile with relevance to immune surveillance and multiple sclerosis.
- Published in:
- Brain Communications, 2021, v. 3, n. 3, p. 1, doi. 10.1093/braincomms/fcab155
- By:
- Publication type:
- Article
Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor During Alemtuzumab Therapy: Evidence that the Thyrotropin Receptor May Precede Thyroid Dysfunction by Many Years.
- Published in:
- Thyroid, 2018, v. 28, n. 12, p. 1682, doi. 10.1089/thy.2018.0232
- By:
- Publication type:
- Article